Increased Transparency in Generic Drug Approvals
New rules aim to make it easier for generic drug companies to get information from a government agency about whether their product is identical to the original drug. This is intended to speed up the introduction of cheaper drug alternatives to the market, potentially impacting the availability and cost of treatment for citizens.
Key points
Generic drug companies can now ask the government agency if their drug is the same as the original.
The agency must respond and point out any differences in ingredients or amounts.
If the agency confirms the drug is identical, it cannot change this decision unless the original drug was withdrawn for safety reasons or the agency made an error.
The agency has one year to develop guidelines on how it will assess drug identity.
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.